741
Participants
Start Date
January 6, 2010
Primary Completion Date
July 1, 2010
Study Completion Date
July 16, 2010
FFNS 110 mcg QD
Active Nasal Spray (AM) and Placebo Nasal Spray (PM)
FFNS 110 mcg BID
Active Nasal Spray (AM) and Active Nasal Spray (PM)
Placebo Nasal Spray
Placebo Nasal Spray (AM) and Placebo Nasal Spray (PM)
GSK Investigational Site, Sofia
GSK Investigational Site, Bekkestua
GSK Investigational Site, Sofia
GSK Investigational Site, Sofia
GSK Investigational Site, Hamar
GSK Investigational Site, Elverum
GSK Investigational Site, Stavanger
GSK Investigational Site, Rousse
GSK Investigational Site, Varna
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Tallinn
GSK Investigational Site, Ketzin
GSK Investigational Site, Hamburg
GSK Investigational Site, Madrid
GSK Investigational Site, Hanover
GSK Investigational Site, Essen
GSK Investigational Site, Talavera de La Reina (Toledo)
GSK Investigational Site, Duisburg
GSK Investigational Site, Goch
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, Odesa
GSK Investigational Site, Wiesbaden
GSK Investigational Site, Zaporizhzhya
GSK Investigational Site, Weinheim
GSK Investigational Site, Nuremberg
GSK Investigational Site, Symferopil
GSK Investigational Site, Moscow
GSK Investigational Site, Moscow
GSK Investigational Site, Moscow
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Chilliwack
GSK Investigational Site, Kelowna
GSK Investigational Site, Surrey
GSK Investigational Site, Winnipeg
GSK Investigational Site, Winnipeg
GSK Investigational Site, Ajax
GSK Investigational Site, Brampton
GSK Investigational Site, Greater Sudbury
GSK Investigational Site, Hamilton
GSK Investigational Site, London
GSK Investigational Site, Mississauga
GSK Investigational Site, Newmarket
GSK Investigational Site, Oshawa
GSK Investigational Site, Ottawa
GSK Investigational Site, Sarnia
GSK Investigational Site, Toronto
GSK Investigational Site, Toronto
GSK Investigational Site, Toronto
GSK Investigational Site, Woodstock
GSK Investigational Site, Granby
GSK Investigational Site, Pointe-Claire
GSK Investigational Site, Québec
GSK Investigational Site, Québec
GSK Investigational Site, Saskatoon
GSK Investigational Site, Benešov
GSK Investigational Site, Brno
GSK Investigational Site, Hradec Králové
GSK Investigational Site, Pardubice
GSK Investigational Site, Prague
GSK Investigational Site, Delitzsch
GSK Investigational Site, Schmölln
GSK Investigational Site, Almere Stad
GSK Investigational Site, Beek
GSK Investigational Site, Etten-Leur
GSK Investigational Site, Losser
GSK Investigational Site, Nijmegen
GSK Investigational Site, Woerden
GSK Investigational Site, Ålesund
GSK Investigational Site, Oviedo
GSK Investigational Site, Hønefoss
GSK Investigational Site, Nesttun
GSK Investigational Site, Lublin
GSK Investigational Site, Tarnów
GSK Investigational Site, Wroclaw
GSK Investigational Site, Wroclaw
GSK Investigational Site, Zawadzkie
GSK Investigational Site, Barcelona
GSK Investigational Site, Benidorm/Alicante
GSK Investigational Site, Petrer/Alicante
GSK Investigational Site, Gothenburg
GSK Investigational Site, Gothenburg
GSK Investigational Site, Lidingö
GSK Investigational Site, Lund
GSK Investigational Site, Stockholm
GSK Investigational Site, Kyiv
GSK Investigational Site, Kyiv
Lead Sponsor
GlaxoSmithKline
INDUSTRY